Cargando…

Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles

PURPOSE: Photothermal ablation is a minimally invasive approach, which typically involves delivery of photothermal sensitizers to targeted tissues. The purpose of our study was to demonstrate that gold nanoparticles are phagocytosed by pancreatic cancer cells, thus permitting magnetic resonance imag...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yang, Zhang, Zhuoli, Kim, Dong-Hyun, Li, Weiguo, Nicolai, Jodi, Procissi, Daniel, Huan, Yi, Han, Guohong, Omary, Reed A, Larson, Andrew C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771851/
https://www.ncbi.nlm.nih.gov/pubmed/24039426
http://dx.doi.org/10.2147/IJN.S47585
_version_ 1782284233840001024
author Guo, Yang
Zhang, Zhuoli
Kim, Dong-Hyun
Li, Weiguo
Nicolai, Jodi
Procissi, Daniel
Huan, Yi
Han, Guohong
Omary, Reed A
Larson, Andrew C
author_facet Guo, Yang
Zhang, Zhuoli
Kim, Dong-Hyun
Li, Weiguo
Nicolai, Jodi
Procissi, Daniel
Huan, Yi
Han, Guohong
Omary, Reed A
Larson, Andrew C
author_sort Guo, Yang
collection PubMed
description PURPOSE: Photothermal ablation is a minimally invasive approach, which typically involves delivery of photothermal sensitizers to targeted tissues. The purpose of our study was to demonstrate that gold nanoparticles are phagocytosed by pancreatic cancer cells, thus permitting magnetic resonance imaging (MRI) of sensitizer delivery and photothermal ablation. PATIENTS AND METHODS: Iron-oxide core/gold-shell nanoparticles (GoldMag®, 30 nm diameter; Xi’an GoldMag Biotechnology Co, Xi’an, People’s Republic of China) were used. In a 96-well plate, 3 × 10(4) PANC-1 (human pancreatic cancer cell line) cells were placed. GoldMag (0, 25, or 50 μg/mL) was added to each well and 24 hours allowed for cellular uptake. Samples were then divided into two groups: one treated with photothermal ablation (7.9 W/cm(2)) for 5 minutes, the other not treated. Photothermal ablation was performed using laser system (BWF5; B&W Tek, Inc, Newark, DE, USA). Intraprocedural temperature changes were measured using a fiber optic temperature probe (FTP-LN2; Photon Control Inc, Burnaby, BC, Canada). After 24 hours, the remaining number of viable cells was counted using trypan blue staining; cell proliferation percentage was calculated based on the total number of viable cells after treatment compared with control. MRI of GoldMag uptake was performed using a 7.0T ClinScan system (Bruker BioSpin, Ettlingen, Germany). RESULTS: Temperature curves demonstrated that with increased GoldMag uptake, laser irradiation produced higher temperature elevations in the corresponding samples; temperature elevations of 12.89°C, 35.16°C, and 79.51°C were achieved for 0, 25, and 50 μg/mL GoldMag. Without photothermal ablation, the cell proliferation percentage changed from 100% to 71.3% and 47.0% for cells treated with 25 and 50 μg/mL GoldMag. Photothermal ablation of PANC-1 cells demonstrated an effective treatment response, specifically a reduction to only 61%, 21.9%, and 2.3% cell proliferation for cells treated with 0, 25, and 50 μg/mL GoldMag. MRI was able to visualize GoldMag uptake within PANC-1 cells. CONCLUSION: Our findings suggest that photothermal ablation may be effective in the treatment of pancreatic cancer. GoldMag nanoparticles could serve as photothermal sensitizers, and MRI is feasible to quantify delivery.
format Online
Article
Text
id pubmed-3771851
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37718512013-09-13 Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles Guo, Yang Zhang, Zhuoli Kim, Dong-Hyun Li, Weiguo Nicolai, Jodi Procissi, Daniel Huan, Yi Han, Guohong Omary, Reed A Larson, Andrew C Int J Nanomedicine Original Research PURPOSE: Photothermal ablation is a minimally invasive approach, which typically involves delivery of photothermal sensitizers to targeted tissues. The purpose of our study was to demonstrate that gold nanoparticles are phagocytosed by pancreatic cancer cells, thus permitting magnetic resonance imaging (MRI) of sensitizer delivery and photothermal ablation. PATIENTS AND METHODS: Iron-oxide core/gold-shell nanoparticles (GoldMag®, 30 nm diameter; Xi’an GoldMag Biotechnology Co, Xi’an, People’s Republic of China) were used. In a 96-well plate, 3 × 10(4) PANC-1 (human pancreatic cancer cell line) cells were placed. GoldMag (0, 25, or 50 μg/mL) was added to each well and 24 hours allowed for cellular uptake. Samples were then divided into two groups: one treated with photothermal ablation (7.9 W/cm(2)) for 5 minutes, the other not treated. Photothermal ablation was performed using laser system (BWF5; B&W Tek, Inc, Newark, DE, USA). Intraprocedural temperature changes were measured using a fiber optic temperature probe (FTP-LN2; Photon Control Inc, Burnaby, BC, Canada). After 24 hours, the remaining number of viable cells was counted using trypan blue staining; cell proliferation percentage was calculated based on the total number of viable cells after treatment compared with control. MRI of GoldMag uptake was performed using a 7.0T ClinScan system (Bruker BioSpin, Ettlingen, Germany). RESULTS: Temperature curves demonstrated that with increased GoldMag uptake, laser irradiation produced higher temperature elevations in the corresponding samples; temperature elevations of 12.89°C, 35.16°C, and 79.51°C were achieved for 0, 25, and 50 μg/mL GoldMag. Without photothermal ablation, the cell proliferation percentage changed from 100% to 71.3% and 47.0% for cells treated with 25 and 50 μg/mL GoldMag. Photothermal ablation of PANC-1 cells demonstrated an effective treatment response, specifically a reduction to only 61%, 21.9%, and 2.3% cell proliferation for cells treated with 0, 25, and 50 μg/mL GoldMag. MRI was able to visualize GoldMag uptake within PANC-1 cells. CONCLUSION: Our findings suggest that photothermal ablation may be effective in the treatment of pancreatic cancer. GoldMag nanoparticles could serve as photothermal sensitizers, and MRI is feasible to quantify delivery. Dove Medical Press 2013 2013-09-06 /pmc/articles/PMC3771851/ /pubmed/24039426 http://dx.doi.org/10.2147/IJN.S47585 Text en © 2013 Guo et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Original Research
Guo, Yang
Zhang, Zhuoli
Kim, Dong-Hyun
Li, Weiguo
Nicolai, Jodi
Procissi, Daniel
Huan, Yi
Han, Guohong
Omary, Reed A
Larson, Andrew C
Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles
title Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles
title_full Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles
title_fullStr Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles
title_full_unstemmed Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles
title_short Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles
title_sort photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771851/
https://www.ncbi.nlm.nih.gov/pubmed/24039426
http://dx.doi.org/10.2147/IJN.S47585
work_keys_str_mv AT guoyang photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT zhangzhuoli photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT kimdonghyun photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT liweiguo photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT nicolaijodi photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT procissidaniel photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT huanyi photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT hanguohong photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT omaryreeda photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles
AT larsonandrewc photothermalablationofpancreaticcancercellswithhybridironoxidecoregoldshellnanoparticles